Valuation (36%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 18.74 | 18.03 |
| PEG Ratio (TTM) | -0.25 | 2.22 |
| P/S Ratio (TTM) | 5.83 | 3.43 |
| P/B Ratio (TTM) | 1.33 | 2.09 |
| P/FCF Ratio (TTM) | 3.16 | -4.19 |
| Price to 5YR AVG Earnings Ratio | N/A | 7.89 |
| Price to 5YR AVG FCF Ratio | N/A | -161.56 |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.01% | -1.56% |
| ROE (TTM) | 7.26% | 9.45% |
| Net Profit Margin (TTM) | 24.85% | 17.11% |
| ROIC 5YR AVG | N/A | 11.84% |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -8.93% | 22.12% | N/A |
| Revenue | -3.76% | -9.10% | N/A |
| Net Income | -4.52% | 21.74% | N/A |
| Cash Flow | 166.62% | 5.96% | N/A |
Health (56%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.81 | 2.59 |
| Quick Ratio (TTM) | -1.26 | 2.82 |
| D/E Ratio (TTM) | 0.00 | 3.63 |
| Interest Coverage (TTM) | N/A | 1.15 |
| Piotroski F-Score | 5 | 4 |
| Altman Z-Score | 3.89 | 1.50 |
| LTL to 5YR AVG FCF | N/A | -234.02 |
| Shares Outstanding Growth 5YR AVG | N/A | 2.05% |